TrialClinical lung cancer2022

EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.

Fred R Hirsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.